Skip to main content
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. — Investor Relations & Filings

Ticker · RKDA ISIN · US0390142042 LEI · 54930027ZPNA80B8O763 US Agriculture, forestry and fishing
Open in API
Filings indexed 564 across all filing types
Latest filing 2018-05-09 Interim / Quarterly Rep…
Country US United States of America
Listing US RKDA

About Arcadia Biosciences, Inc.

https://arcadiabio.com/

Arcadia Biosciences, Inc. is a company focused on developing and marketing plant-based health and wellness products. With a foundation in agricultural innovation, the company cultivates next-generation ingredients and consumer goods. Its primary focus is a portfolio of specialty wheat ingredients designed to offer enhanced nutritional benefits, such as increased fiber, improved protein quality, reduced allergenic gluten, and higher amino acid content. Arcadia aims to transform wheat into a functional food ingredient, collaborating with food manufacturers to create healthier formulations of consumer products. In addition to its wheat ingredients, the company's brand portfolio includes Zola, a line of natural coconut water products.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2018
2018-05-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing dated May 9, 2018, reporting the issuance of a press release announcing first-quarter 2018 financial results. The text explicitly states that the press release is furnished as an exhibit and incorporated by reference, and the document itself does not contain detailed financial statements or substantive financial data. The document length is 3681 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the 'Menu vs Meal' rule, this is an announcement of a report (the press release) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such filings that do not contain the full report.
2018-05-09 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 2, 2018, reporting the submission of matters to a vote of security holders at a special meeting. It details the voting results on a proposal related to issuing shares in a private placement. The document is short (3391 characters) and focuses on voting results rather than the full report or financial data. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-05-08 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) under a registration statement. It details the sale or disposition of common stock by selling shareholders, including terms of a private placement, registration rights, and risk factors. It is not a financial report, earnings release, or management discussion, but rather a disclosure document related to securities offering and capital raising. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document length is substantial and contains detailed offering information, confirming it is not a brief announcement or regulatory filing. Therefore, the appropriate classification is CAP.
2018-04-24 English
Regulatory Filings 2018
Regulatory Filings
2018-04-24 English
10-K/A
Annual Report FY 2017
2018-04-13 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.